India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...

The year 2024 was quite extraordinary, with Bitcoin achieving institutional acceptance as the SEC gave permission to launch a ...

Critical pain points need to be overcome for the animal healthcare industry to achieve its full potential.

Promising a "simplification shock", the EU will unveil a much-anticipated blueprint to revamp Europe's economic model on ...

The SGC publishes all findings immediately (&gt, one per week), works closely with &gt,100 academic labs across the world and 6 pharmaceutical companies, and shares all reagents and expertise freely.

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

So far, only eight of the top 100 pharmaceutical companies by global prescription medicines sales have made a net zero commitment in the same date range. This disparity between goals of healthcare ...

We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a ...

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look ...

Learn more about whether The Carlyle Group Inc. or S&P Global Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best ...